Diltor Opromolla

WikiDoc Resources for Diltor Opromolla
Articles
Most recent articles on Diltor Opromolla Most cited articles on Diltor Opromolla Review articles on Diltor Opromolla Articles on Diltor Opromolla in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Diltor Opromolla Images of Diltor Opromolla Photos of Diltor Opromolla Podcasts & MP3s on Diltor Opromolla Videos on Diltor Opromolla
Evidence Based Medicine
Cochrane Collaboration on Diltor Opromolla Bandolier on Diltor Opromolla TRIP on Diltor Opromolla
Clinical Trials
Ongoing Trials on Diltor Opromolla at Clinical Trials.gov Trial results on Diltor Opromolla Clinical Trials on Diltor Opromolla at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Diltor Opromolla NICE Guidance on Diltor Opromolla NHS PRODIGY Guidance FDA on Diltor Opromolla CDC on Diltor Opromolla
Books
Books on Diltor Opromolla
News
Diltor Opromolla in the news Be alerted to news on Diltor Opromolla News trends on Diltor Opromolla
Commentary
Blogs on Diltor Opromolla
Definitions
Definitions of Diltor Opromolla
Patient Resources / Community
Patient resources on Diltor Opromolla Discussion groups on Diltor Opromolla Patient Handouts on Diltor Opromolla Directions to Hospitals Treating Diltor Opromolla Risk calculators and risk factors for Diltor Opromolla
Healthcare Provider Resources
Symptoms of Diltor Opromolla Causes & Risk Factors for Diltor Opromolla Diagnostic studies for Diltor Opromolla Treatment of Diltor Opromolla
Continuing Medical Education (CME)
CME Programs on Diltor Opromolla
International
Diltor Opromolla en Espanol Diltor Opromolla en Francais
Business
Diltor Opromolla in the Marketplace Patents on Diltor Opromolla
Experimental / Informatics
List of terms related to Diltor Opromolla

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Diltor Vladimir Araújo Opromolla (13 April 1934, São Paulo - 15 December 2004, Bauru) was a Brazilian physician and dermatologist internationally respected due to his lifetime work with leprosy patients and leprosy research. Dr. Opromolla performed all his work at Lauro de Souza Lima Institute in Bauru, São Paulo, a WHO reference hospital for dermatology. He taught dermatology and leprosy to countless doctors, nurses, and other health workers. Among other things, he was the first to introduce rifamycin in the treatment of leprosy, in 1963.

Dr. Opromolla battled gastric cancer for the whole year of 2004 and died on December 15, 2004.

References

• Fleury, RN. Diltor Vladimir Araújo Opromolla. Anais Brasileiros de Dermatologia, 80(4), July/Aug. 2005. Biography and obituary.
• Tribute Paid to Doctor Diltor Vladimir Araújo Opromolla, Symbol of the Fight against Hansen's Disease. Pan American Health Organization.
• Naafs B, Silva E, Vilani-Moreno F, Marcos EC, Nogueira ME, Opromolla DV. Factors influencing the development of leprosy: an overview. Int J Lepr Other Mycobact Dis. 2001 Mar;69(1):26-33. Review. PMID 11480313
• Limalde S, Opromolla DV. First results on the treatment of leprosy with rifamycin. Chemotherapy. 1963;10:668-78.

External links

• Search for Dr. Opromolla's international research papers. PubMed (US National Library of Medicine).
• Search for Dr. Opromolla's full text papers at the SciElo database.
• Instituto Lauro de Souza Lima. Home Page.